Low dose spironolactone and cardiovascular outcomes in moderate stage chronic kidney disease: the BARACK-D randomised trial
1 September 2024 (16:15 - 16:30)
Organised by: 
Slides
About the speakers
University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)
Oxford (United Kingdom of Great Britain & Northern Ireland)
3 More presentations in this session
Assistant Professor Y. Reddy (Rochester, US)
Doctor A. Perry (Nashville, US)
Access the full session
The Event
ESC Congress 2024
1 September 2024
16:15 CET
You may be interested in
Congress Session
Congress Presentation
